Erica Schneider, MD
Pulmonary Disease · Williamsburg, VANPI 1659646990
Payments from drug & device makers
Across 197 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$667
- AstraZeneca$514
- Philips North America LLC$255
- Mallinckrodt Enterprises LLC$168
- Grifols USA, LLC$160
- Amgen$153
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,520100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 46 | $667 |
| AstraZeneca | 29 | $514 |
| Philips North America LLC | 15 | $255 |
| Mallinckrodt Enterprises LLC | 10 | $168 |
| Grifols USA, LLC | 8 | $160 |
| Amgen | 8 | $153 |
| Actelion Pharmaceuticals US, Inc. | 5 | $146 |
| Boehringer Ingelheim | 7 | $129 |
| Novartis | 5 | $116 |
| Genentech USA, Inc. | 5 | $98 |
| Electromed, Inc. | 6 | $92 |
| Sanofi | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $83 |
| Pfizer | 4 | $77 |
| Mylan Specialty L.p. | 4 | $74 |
| Insmed, Inc. | 4 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
| Pulmonx Corporation | 2 | $52 |
| Advanced Respiratory, Inc | 3 | $50 |
| Mallinckrodt Hospital Products Inc. | 2 | $48 |
| AbbVie(2 entities) | 2 | $41 |
| Boston Scientific | 1 | $40 |
| Bristol Myers Squibb | 2 | $39 |
| Resmed Corp | 2 | $38 |
| Circassia Inc. | 3 | $36 |
| Jazz Pharmaceuticals Inc. | 3 | $35 |
| Lilly USA, LLC | 2 | $35 |
| Melinta Therapeutics, LLC | 1 | $31 |
| Abbott | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| ZOLL Circulation Inc | 1 | $17 |
| Optinose US, Inc. | 1 | $16 |
| Gilead | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Harmony Biosciences LLC | 1 | $14 |
How this compares
$3,520 in reported general payments places this provider in the 50th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Williamsburg
- Vijay SubramaniamWilliamsburg$1.3M
- Steven NathanFalls Church$2.5M
- Shilpa JohriRichmond$1.7M
- Omar MinaiHopewell$1.3M
- Rabih HalabiFalls Church$604K
- Patricia SimeRichmond$572K
- Apostolos PerelasRichmond$567K
- Hannah MannemCharlottesville$326K
- Ray ShepherdRichmond$303K
- Eric LibreAnnandale$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.